[1] |
Wolff G, Lin Y, Quade J, et al. Validation of National Cardiovascular Data Registry risk models for mortality, bleeding and acute kidney injury in interventional cardiology at a German Heart Center[J]. Clin Res Cardiol, 2020, 109(2):235-245.
|
[2] |
Caspi O, Habib M, Cohen Y, et al. Acute kidney injury after primary angioplasty: Is contrast-induced nephropathy the culprit[J/OL]? J Am Heart Assoc, 2017, 6(6):e005715.
|
[3] |
El-Ahmadi A, Abassi MS, Andersson HB, et al. Acute kidney injury - A frequent and serious complication after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction[J/OL]. PLoS One, 2019, 14(12):e0226625.
|
[4] |
Silvain J, Nguyen LS, Spagnoli V, et al. Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention[J]. Heart, 2018, 104(9):767-772.
|
[5] |
Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation[J]. J Am Coll Cardiol, 2004, 44(7):1393-1399.
|
[6] |
Wächter C, Markus B, Schieffer B. Cardiac causes of chest pain[J]. Internist (Berl), 2017, 58(1):8-21.
|
[7] |
Anand A, Cudmore S, Robertson S, et al. Frailty assessment and risk prediction by GRACE score in older patients with acute myocardial infarction[J]. BMC Geriatr, 2020, 20(1):102.
|
[8] |
中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南(2019)[J].中华心血管病杂志,2019,47(10):766-783.
|
[9] |
全国eGFR课题协作组. MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595.
|
[10] |
Puymirat E, Simon T, Cayla G, et al. Acute myocardial infarction: Changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the FAST-MI program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015[J]. Circulation, 2017, 136(20):1908-1919.
|
[11] |
Tsai TT, Patel UD, Chang TI, et al. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: Insights from the NCDR Cath-PCI registry[J]. JACC Cardiovasc Interv, 2014, 7(1):1-9.
|
[12] |
Schmucker J, Fach A, Becker M, et al. Predictors of acute kidney injury in patients admitted with ST-elevation myocardial infarction - results from the Bremen STEMI-Registry[J]. Eur Heart J Acute Cardiovasc Care, 2018, 7(8):710-722.
|
[13] |
胡海鹰,于亚梅,余云华,等.老年急性心肌梗死患者经皮冠状动脉介入治疗的近远期预后[J].中国老年学杂志,2019,39(9):2049-2052.
|
[14] |
Ronco C, McCullough P, Anker SD, et al. Cardio-renal syndromes: Report from the consensus conference of the acute dialysis quality initiative[J]. Eur Heart J, 2010, 31(6):703-711.
|
[15] |
Shacham Y, Leshem-Rubinow E, Gal-Oz A, et al. Acute cardio-renal syndrome as a cause for renal deterioration among myocardial infarction patients treated with primary percutaneous intervention[J]. Can J Cardiol, 2015, 31(10):1240-1244.
|
[16] |
刘倩倩,伏蕊,宋晨曦,等.中国急性心肌梗死患者住院期间死亡的危险因素分析[J].中国循环杂志,2020,35(1):24-30.
|
[17] |
李其华,韦金儒,唐泉,等.肾小球滤过率对急性心肌梗死患者直接经皮冠状动脉介入术后预后的影响[J].中国全科医学,2016,19(36):4456-4460.
|
[18] |
苏昱润,潘晨亮,彭瑜,等.急性ST段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后并发对比剂诱导的急性肾损伤的危险因素分析[J].中国循环杂志,2021,36(3):245-250.
|
[19] |
Guerchicoff A, Stone GW, Mehran R, et al. Analysis of biomarkers for risk of acute kidney injury after primary angioplasty for acute ST-segment elevation myocardial infarction: Results of the HORIZONS-AMI trial[J]. Catheter Cardiovasc Interv, 2015, 85(3):335-342.
|
[20] |
Dogné S, Flamion B. Endothelial glycocalyx impairment in disease: Focus on hyaluronan shedding[J]. Am J Pathol, 2020, 190(4):768-780.
|